Banka BioLoo Limited private wins cut Rail share to 30% in Q2
Key highlights
- Rail represented about 30% of Banka BioLoo’s Rs 83.4 crore unexecuted order book at 30 September 2026, versus about 39% at 30 June 2026.
- Private customers supplied 100% of Banka BioLoo’s Rs 16 crore Q2 FY26-27 order bookings.
- Non-Rail unexecuted orders increased to Rs 58.5 crore at September 2026 from Rs 49.8 crore at June 2026.
- Standalone H1 FY26-27 profit after tax was Rs 78.7 lakh, compared with a Rs 96.8 lakh loss a year earlier.
powered by IRIS

Banka BioLoo Limited reduced Rail’s share of its unexecuted order book to about 30% at 30 September 2026 from about 39% three months earlier, after private clients provided all Rs 16 crore of second-quarter FY26-27 bookings; management linked the shift from long-cash-cycle government work to better cash-flow management.
Know Banka Bioloo inside out
Results, valuation, peers and who's buying, in one view.
How did Banka BioLoo reduce Rail exposure in its order book?
Banka BioLoo reduced Rail’s portion of unexecuted orders during Q2 FY26-27, the second quarter of financial year 2026-27. Rail orders fell to Rs 24.9 crore at 30 September 2026 from Rs 32 crore at 30 June 2026, while the total unexecuted book increased to Rs 83.4 crore from Rs 81.8 crore. This moved Rail’s share to about 30% from about 39% over the quarter.
Non-Rail orders rose by Rs 8.7 crore in the quarter, exceeding the Rs 7.1 crore reduction in the Rail balance. Management described the intended mix change as lower dependence on government and Rail work with long cash cycles and a greater contribution from Category A+ private customers. Rail remains part of Banka BioLoo’s offering, which includes bio-toilet operations and maintenance, periodic overhauling, quick watering systems and coach-upgrade work.
What did Banka BioLoo book from private customers in Q2?
Banka BioLoo booked Rs 16 crore of orders in Q2 FY26-27, with private customers accounting for 100% of that amount, compared with Rs 4.2 crore booked in Q1 FY26-27. The presentation identifies KRT, a data-centre sanitation-infrastructure order and multiple operations-and-maintenance orders among Q2 wins. It says the data-centre contract opens a new line of business.
Notable first-half FY26-27 wins also included Auro Infra in Hyderabad and expansion into Bengaluru and Mumbai with Brigade, Reliance and RMZ. Banka BioLoo additionally cited bio-toilet projects from construction customers and developers in Hyderabad. The source does not disclose the value allocated to each customer or project, so the Rs 16 crore total is the available measure of private-client booking in Q2.
These projects sit within Banka BioLoo’s Non-Rail activities, which include engineering, procurement and construction, operations and maintenance, bio-digesters and faecal septage treatment plants. The company reported more than 12 million litres per day of faecal sludge treated and more than 4 billion litres of used water treated through its operations, while also servicing more than 25,000 Railway systems daily. Those operating measures show that the order-mix change applies within a business that continues to serve both Rail and Non-Rail customers.
How has Banka BioLoo’s order book changed since March 2026?
Banka BioLoo reported an order book of Rs 107 crore at 31 March 2026 and identified about Rs 70 crore for execution in the following 12 months. Management characterised that Rs 70 crore figure as an execution estimate rather than guaranteed revenue. The unexecuted balance was subsequently Rs 81.8 crore at 30 June and Rs 83.4 crore at 30 September, following bookings of Rs 4.2 crore in Q1 and Rs 16 crore in Q2.
The presentation does not provide a full reconciliation between the Rs 107 crore March order book and the Rs 83.4 crore unexecuted balance in September. It does disclose that Non-Rail represented Rs 58.5 crore, or about 70%, of the September balance, compared with Rs 49.8 crore, or about 61%, at June end. The disclosed change was therefore both a lower Rail balance and a higher Non-Rail balance.
Execution was under way on commercial assets in Hyderabad, while assets in Mumbai and Bengaluru were under commissioning at 30 September 2026. Banka BioLoo also listed a quick watering system project in Kerala as under commissioning. These stages are relevant because order booking and the unexecuted balance do not establish the timing of revenue recognition, cash receipts or profit.
Got a follow-up? Ask IRIS
What financial change accompanied the private-client shift?
Banka BioLoo’s standalone total income rose 24.5% year on year to Rs 16.56 crore in Q2 FY26-27 from Rs 13.30 crore in Q2 FY25-26. Earnings before interest, tax, depreciation and amortisation, or EBITDA, were Rs 1.57 crore, compared with a loss of Rs 39.5 lakh a year earlier. Profit after tax was Rs 41.6 lakh, versus a Rs 1.10 crore loss in the prior-year quarter.
For the first half, or H1, of FY26-27, standalone income increased 22.5% to Rs 32.96 crore from Rs 26.91 crore. H1 EBITDA reached Rs 3.08 crore from Rs 64 lakh, while profit after tax was Rs 78.7 lakh against a Rs 96.8 lakh loss in H1 FY25-26. Management attributed the turnaround to the movement from long-cash-cycle government orders to private customers and its stated effect on cash-flow management and turnaround speed.
Standalone operating cash flow was Rs 1.88 crore in H1 FY26-27, compared with Rs 1.06 crore in the comparison period cited in the presentation. Receivables were Rs 26 crore at the end of H1, up from Rs 25.67 crore at 31 March 2026. The source therefore reports higher operating cash flow and profitability alongside a rise in receivables, rather than providing a project-by-project collection analysis.
What should readers watch in Banka BioLoo’s next execution phase?
Banka BioLoo’s FY27 scorecard calls for commissioning projects, collecting receivables, delivering sustainable profit before tax, funding growth prudently and digitising monitoring. In Q2, it reported five sewage treatment plants and multiple smaller projects completed, with four commissioned and four under commissioning across engineering projects and Megaliter Varunaa. The next updates can indicate whether those projects convert the Rs 83.4 crore unexecuted book into income and cash.
Megaliter Varunaa is also central to the company’s stated recurring-revenue plan. At H1 FY26-27, the platform had 16 contracted projects, of which 13 were commissioned and three were work in progress, with 11 million litres per day of contracted treatment capacity and more than Rs 140 crore of contracted lifetime value. Banka BioLoo said about 80% of that lifetime value was yet to be recognised.
Funding remains a disclosed monitoring item. Consolidated net debt to equity was 0.82 times at H1 FY26-27, compared with 0.74 times at 31 March 2026, while Megaliter Varunaa’s H1 capital expenditure was Rs 12.43 crore. Management’s ambition to recycle more than 15 billion litres of water annually by 2030 is explicitly not FY27 guidance.
Conclusion
Banka BioLoo’s Q2 disclosure shows a measurable movement in the active order mix: Non-Rail work reached Rs 58.5 crore and Rail work declined to Rs 24.9 crore, leaving Rail at about 30% of the Rs 83.4 crore unexecuted book. All Rs 16 crore of Q2 bookings came from private clients, alongside higher standalone income, a return to quarterly profit after tax and Rs 1.88 crore of H1 operating cash flow.
The next points to watch are delivery against the roughly Rs 70 crore identified for execution in the next 12 months and commissioning in Mumbai, Bengaluru and Kerala. Banka BioLoo’s FY27 plan also makes receivables, which rose to Rs 26 crore from Rs 25.67 crore at March, and consolidated net debt to equity of 0.82 times matters to track as Megaliter Varunaa expands its contracted portfolio.


